Digestive Health

The Pharmacy Times® Digestive Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to health of the digestive system, including Crohn disease, inflammatory bowel disease, irritable bowel syndrome, and ulcerative colitis.

Medications Can Exacerbate Symptoms of Celiac Disease

May 19, 2022

Article

Be aware of products containing gluten, nonsteroidal anti-inflammatory drugs, and olmesartan.

Daily OTC Pearl: Docusate Sodium

May 18, 2022

Article

Docusate treats occasional constipation by reducing surface tension and emulsification of fecal matter, which allows water to penetrate and mix with and soften stool.

Daily Medication Pearl: Obeticholic Acid (Ocaliva)

May 13, 2022

Article

Obeticholic acid (Ocaliva) is indicated for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.

Daily OTC Pearl: Phazyme

May 13, 2022

Article

Phazyme is used to treat symptoms of gas, such as belching, bloating, and pressure in the stomach/gut.

AbbVie’s Upadacitinib Achieves Positive Results for Treatment of Crohn Disease

May 12, 2022

Article

A significantly greater proportion or patients treated with either 15 or 30 mg show remission or endoscopic response or remission at week 52 compared with the placebo.

FDA Approves Generic Mesalamine Extended Release Capsules for Ulcerative Colitis

May 12, 2022

Article

Mesalamine is used to treat and prevent flare-ups of mild to moderately active ulcerative colitis.

Daily Medication Pearl: Vedolizumab (Entyvio)

May 10, 2022

Article

Vedolizumab (Entyvio) is indicated for adult patients with moderately to severely active ulcerative colitis and adult patients with moderately to severely active Crohn disease.

Daily OTC Pearl: Oxy-Powder

May 10, 2022

Article

Oxy-Powder is designed to clean the digestive tract and oxidize and decrease the amount of impacted fecal matter.

FDA Approves Pair of Vonoprazan Treatments for Helicobacter Pylori Infection

May 04, 2022

Article

The Voquezna Triple Pak (vonoprazan, amoxicillin, clarithromycin) and Voquezna Dual Pak (vonoprazan, amoxicillin) were previously granted priority review designation by the FDA for H. pylori infection.

Daily OTC Pearl: Prunelax

April 29, 2022

Article

Prunelax is a laxative made of natural Senna leaves to relieve occasional constipation.